Researchers illuminate potential precursors of blood cancers
Researchers from University of Utah, USA, report significant new insights into the development of blood…
Browsing: blood cancer
Improving immunotherapies for blood cancers: real-time exploration in the tumour
Monoclonal antibodies are part of the therapeutic arsenal for eliminating cancer cells. Some make use…
Research findings could reduce treatment-related complication for blood cancer patients
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, USA, published promising…
Why do certain chemotherapies increase the likelihood of blood cancer?
In recent years, improvements in cancer therapy have led to a significant increase in cancer…
New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of…
Benefits of Venetoclax endure years after blood cancer clinical trial
A study which tracked the long-term outcomes of blood cancer patients involved in the MURANO…
Large international study pinpoints impact of TP53 gene mutations on blood cancer severity
Considered the “guardian of the genome,” TP53 is the most commonly mutated gene in cancer.…
UNSW to lead new drug trial for rare blood cancer
UNSW Sydney researchers will conduct a clinical trial to establish the safety and efficacy of…
Impact of COVID-19 infection in blood cancer patients
One of the first studies to investigate the outcome of COVID-19 infection in patients with…
Clinical trial announced to study impact of severe COVID-19 infection on patients who receive stem cell transplants for blood cancers and disorders
A new study will look at how patients, who receive stem cell transplants for blood…